Key facts
- This page summarizes SMITH ALAN E's Form 3 filing for Candel Therapeutics, Inc. (CADL).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 26 Jul 2021, 21:24.
SMITH ALAN E - 26 Jul 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)
- Reporting relationship
- Director
- Issuer ticker
- CADL
- Reported as of
- 26 Jul 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Alan E. Smith
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
SMITH ALAN E filed Form 3 for Candel Therapeutics, Inc. (CADL) on 26 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CADL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 32,548
- Date
- 26 Jul 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CADL
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,068
- Exercise price
- $1.46
- Footnotes
- F1
CADL
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,274
- Exercise price
- $1.55
- Footnotes
- F2
CADL
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 26 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,274
- Exercise price
- $6.64
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
25% of this option vested and became exercisable on May 28, 2019, with an additional 25% vesting on January 1, 2020 and the remainder vesting in 36 substantially equal monthly installments thereafter.
Footnote F2
This option is fully vested and exercisable as of the date hereof.